Although an overwhelming 98% of cancer patients wanted to know the results of the clinical trial they took part in, there is currently no standard way of conveying the information. The onus is usually placed on the patient to find out the results from their doctor. Over 1,400 people with cancer took part in a new study to determine the best way of telling patients about their clinical trial results, the findings of which were announced today at the 5th European Breast Cancer Conference (EBCC-5).
The study by the TACT (Taxotere as Adjuvant ChemoTherapy) trial management group, questioned UK patients involved in clinical trials and asked if they would like to be notified of the results when available, and if so, how they would like the results conveyed. Advantages and disadvantages of each method were explained. A similar survey of health care professionals was conducted simultaneously.
Stella Kyriakides, Co-Chair of EBCC-5 and past president of Europa Donna comments, “Some breast cancer patients take part in a clinical trial and are never told the results. It is important that patients are not forgotten after they have participated in a study that ultimately improves cancer treatment for all patients.”
EBCC-5 Press Office | alfa
Foods of the future
15.08.2018 | Georg-August-Universität Göttingen
New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
15.08.2018 | Physics and Astronomy
15.08.2018 | Earth Sciences
15.08.2018 | Physics and Astronomy